WST · West Pharmaceutical Services, Inc.
$350.852026-07-21Sector: Healthcare; Industry: Medical - Instruments & Supplies; Sub-Industry: Health Care Supplies
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$133
-62.0% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($128 · $158) Analysts Range ($295 · $400) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $3.0B | — | 24.1% | 16.8% | $591MM | −$237MM | $354MM | 9.2% | — | 25.7% | $2.3B | $8.20 | — |
| 2024.Q4 | $3.0B | 0.0% | 24.1% | 17.9% | $584MM | −$219MM | $365MM | 9.5% | — | 24.7% | $2.4B | $8.20 | — |
| 2025.Q1 | $2.9B | -2.0% | 20.6% | 19.8% | $477MM | −$161MM | $316MM | 9.8% | — | 19.4% | $2.5B | $6.81 | — |
| 2025.Q4 | $2.9B | 0.0% | 20.6% | 19.8% | $477MM | −$50MM | $427MM | 9.5% | — | 18.7% | $2.6B | $6.81 | — |
| 2026.Q1 | $3.2B | 11.3% | 20.7% | 20.9% | $527MM | −$119MM | $408MM | 9.5% | — | 19.9% | $2.7B | $7.50 | 38.2 |
| italics below = DCF projection · 10yr Rev CAGR: 5.3% |
| 2027.Q1 | $3.4B | +5.1% | 20.1% | 20.8% | $540MM | −$79MM | $462MM | 9.3% | $422MM | 19.8% | $2.8B | $7.46 | 47.0 |
| 2028.Q1 | $3.6B | +6.3% | 20.1% | 20.7% | $575MM | −$118MM | $457MM | 9.3% | $382MM | 20.3% | $2.9B | $7.94 | 44.2 |
| 2029.Q1 | $3.8B | +7.0% | 20.1% | 20.6% | $616MM | −$168MM | $448MM | 9.2% | $343MM | 20.7% | $3.1B | $8.50 | 41.3 |
| 2030.Q1 | $4.1B | +5.7% | 20.1% | 20.5% | $652MM | −$136MM | $515MM | 9.1% | $362MM | 20.9% | $3.2B | $9.00 | 39.0 |
| 2031.Q1 | $4.3B | +5.5% | 20.1% | 20.4% | $688MM | −$146MM | $542MM | 9.0% | $350MM | 21.1% | $3.3B | $9.50 | 36.9 |
|
| Term. Yr+ | $5.6B | 4.1% | 18.2% | 20.0% | $817MM | −$173MM | $644MM | 8.6% | $6.1B | 19.4% | — | — | — |
Active scenario IV: $133 (-62.0% vs market)